Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Equillium, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 7.32M | 7.19M | −131.9K (−1.8%) |
| Value | $49.9M | $27.0M | −$22.9M (−45.9%) |
New holders (7)
Institutions that held Equillium, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 10,109 | $38.0K | 0.00% |
| Simplex Trading, LLC | 7,119 | $26.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,476 | $13.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,209 | $4.56K | 0.00% |
| CWM, LLC | 300 | $1.00K | 0.00% |
| Bank of America Corp | 34 | $0 | 0.00% |
| AdvisorNet Financial, Inc | 19 | $0 | 0.00% |
Sold out (3)
Institutions that held Equillium, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 14,130 | $96.0K |
| Koshinski Asset Management, Inc. | 1,000 | $6.82K |
| Barclays PLC | 15 | $0 |